Luye Pharma Group Ltd Financials

Market Capitalization HK$7.56 Billion as of Jan. 1, 2025

Valuations Metrics as of Jan. 25, 2025

Trailing PE	9.14
Forward PE	7.44
Price to Sales TTM	HK$1.20
Price to Book MRQ	HK$0.58
Enterprise to Revenue	1.84
Enterprise to EBITDA	5.89

Financial Reports as of Jun. 30, 2012

Financials

Fiscal Year Ends	2023-12-31
Most Recent Quarter	2012-06-30
Profit Margin	12.20%
Operating Margin	19.66%
Return on Assets TTM	3.00%
Return on Equity TTM	6.33%

Income Statement

Revenue TTM	HK$6,706,197,976
Revenue per Share TTM	HK$1.68
Quarterly Revenue Growth	5.90%
Gross Profit TTM	HK$4,609,231,041
EBITDA	HK$336,593,000
Net Income to Common TTM	HK$818,379,926
Diluted EPS TTM	HK$0.22
Quarterly Earnings Growth YoY	158.60%

Balance Sheet

Total Cash MRQ	HK$6,883,008,556
Total Cash per Share MRQ	HK$1.72
Total Debt MRQ	HK$
Total Debt to Equity MRQ	67.12
Current Ratio MRQ	1.28
Book Value per Share MRQ	HK$3.46

Cash Flow

Operating Cash Flow TTM	HK$543,161,989
Levered Free Cash Flow TTM	HK$-1,511,717,437

2186 Stock Info as of Jan. 25, 2025

Stock Statistics

Shares Outstanding	3,761,669,888
Float Shares	1,950,162,911
Avg 10 Volume	18,747,972
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	33.53%
% Held by Institutions	34.84%

Stock Price Summary

Beta	0.85
Fifty Two Week Low	HK$1.98
Fifty Two Week High	HK$3.75
Fifty Two Week Change	-37.50%
Day 50 MA	HK$2.40
Day 200 MA	HK$2.77

Dividends and Splits

Forward Annual Dividend Rate	HK$0.12
Forward Annual Dividend Yield	5.77%
Trailing Annual Dividend Rate	HK$0.13
Trailing Annual Dividend Yield	6.11%
Payout Ratio	0.00%
Dividend Date
Ex Dividend Date	2020-06-29
Last Split Factor
Last Split Date